This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Neurologists are familiar with MRI as T1-, T2-, and proton density–weighted images, and, recently, magnetic resonance angiography (MRA). Here, we draw attention to newer MRI methods—diffusion-weighted imaging (DWI) and perfusion imaging (PI)—that are unique among all imaging methods in their sensitivity to pathophysiologic changes underlying acute stroke. Documentation in clinical studies is now sufficiently compelling to warrant careful consideration of DWI and PI by all physicians who care for patients with acute stroke syndrome.
Conventional MRI methods usually detect ischemic lesions after a few hours, well before clear changes appear on x-ray CT, and with much greater anatomic resolution. The increased sensitivity is particularly obvious in the posterior fossa, where imaging artifacts can mask acute CT changes. However, the advantages of MRI for stroke diagnosis have not yet been documented by clinical outcome studies comparing it directly with CT, which led Powers and Zivin to express well-reasoned reservations about whether MRI is so clearly superior as to justify the costs in money and procedural adjustment that its rapid general adoption would require.1
We believe that recent literature on DWI and PI has tipped the balance definitively in favor of accelerated implementation of MRI as the principal imaging modality for initial evaluation of acute stroke syndrome. This issue of Neurology contains two articles2,3 and a review4 providing new support for that position. Their independent submission to a single journal within a few weeks of each other accurately reflects the pace of development in the field.
The techniques.
Diffusion-weighted imaging. Diffusion in liquids occurs by Brownian motion, the random process of molecular displacements caused by thermal agitation. DWI measures the diffusive motion of water molecules as an apparent diffusion coefficient (ADC), which varies with location in biologic tissue. The anatomic differences can be rendered as an image by standard …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.